BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 33382910)

  • 1. Report of the 21st Nationwide Follow-up Survey of Primary Liver Cancer in Japan (2010-2011).
    Kudo M; Izumi N; Kokudo N; Sakamoto M; Shiina S; Takayama T; Tateishi R; Nakashima O; Murakami T; Matsuyama Y; Takahashi A; Miyata H; Kubo S
    Hepatol Res; 2021 Apr; 51(4):355-405. PubMed ID: 33382910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Report of the 22nd nationwide follow-up Survey of Primary Liver Cancer in Japan (2012-2013).
    Kudo M; Izumi N; Kokudo N; Sakamoto M; Shiina S; Takayama T; Tateishi R; Nakashima O; Murakami T; Matsuyama Y; Takahashi A; Miyata H; Kubo S
    Hepatol Res; 2022 Jan; 52(1):5-66. PubMed ID: 34050584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Report of the 23rd nationwide follow-up survey of primary liver cancer in Japan (2014-2015).
    Iijima H; Kudo M; Kubo S; Kurosaki M; Sakamoto M; Shiina S; Tateishi R; Osamu N; Fukumoto T; Matsuyama Y; Murakami T; Takahashi A; Miyata H; Kokudo N
    Hepatol Res; 2023 Oct; 53(10):895-959. PubMed ID: 37574758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Report of the 20th Nationwide follow-up survey of primary liver cancer in Japan.
    Kudo M; Izumi N; Kubo S; Kokudo N; Sakamoto M; Shiina S; Tateishi R; Nakashima O; Murakami T; Matsuyama Y; Takahashi A; Miyata H; Takayama T
    Hepatol Res; 2020 Jan; 50(1):15-46. PubMed ID: 31655492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Report of the 19th follow-up survey of primary liver cancer in Japan.
    Kudo M; Izumi N; Ichida T; Ku Y; Kokudo N; Sakamoto M; Takayama T; Nakashima O; Matsui O; Matsuyama Y
    Hepatol Res; 2016 Mar; 46(5):372-90. PubMed ID: 26970231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Report of the 16th follow-up survey of primary liver cancer.
    Ikai I; Arii S; Ichida T; Okita K; Omata M; Kojiro M; Takayasu K; Nakanuma Y; Makuuchi M; Matsuyama Y; Yamaoka Y
    Hepatol Res; 2005 Jul; 32(3):163-72. PubMed ID: 16024288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Report of the 18th follow-up survey of primary liver cancer in Japan.
    Ikai I; Kudo M; Arii S; Omata M; Kojiro M; Sakamoto M; Takayasu K; Hayashi N; Makuuchi M; Matsuyama Y; Monden M
    Hepatol Res; 2010 Nov; 40(11):1043-1059. PubMed ID: 34818831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan.
    Ikai I; Arii S; Okazaki M; Okita K; Omata M; Kojiro M; Takayasu K; Nakanuma Y; Makuuchi M; Matsuyama Y; Monden M; Kudo M
    Hepatol Res; 2007 Sep; 37(9):676-91. PubMed ID: 17617112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Report of the 15th follow-up survey of primary liver cancer.
    Ikai I; Itai Y; Okita K; Omata M; Kojiro M; Kobayashi K; Nakanuma Y; Futagawa S; Makuuchi M; Yamaoka Y
    Hepatol Res; 2004 Jan; 28(1):21-29. PubMed ID: 14734147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Surgical treatment of primary liver cancer:a report of 10 966 cases].
    Xia YX; Zhang F; Li XC; Kong LB; Zhang H; Li DH; Cheng F; Pu LY; Zhang CY; Qian XF; Wang P; Wang K; Wu ZS; Lyu L; Rao JH; Wu XF; Yao AH; Shao WY; Fan Y; You W; Dai XZ; Qin JJ; Li MY; Zhu Q; Wang XH
    Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):6-17. PubMed ID: 33412628
    [No Abstract]   [Full Text] [Related]  

  • 11. Nationwide study of 4741 patients with non-B non-C hepatocellular carcinoma with special reference to the therapeutic impact.
    Utsunomiya T; Shimada M; Kudo M; Ichida T; Matsui O; Izumi N; Matsuyama Y; Sakamoto M; Nakashima O; Ku Y; Kokudo N; Makuuchi M;
    Ann Surg; 2014 Feb; 259(2):336-45. PubMed ID: 23673768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
    Liu C; Sun L; Xu J; Zhao Y
    World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of prognostic factors after curative resection for combined hepatocellular and cholangiocarcinoma].
    Kim W; Lee JH; Kim YJ; Yoon JH; Suh KS; Lee KU; Jang JJ; Lee HS
    Korean J Gastroenterol; 2007 Mar; 49(3):158-65. PubMed ID: 18172344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implication of frequent local ablation therapy for intrahepatic recurrence in prolonged survival of patients with hepatocellular carcinoma undergoing hepatic resection: an analysis of 610 patients over 16 years old.
    Taura K; Ikai I; Hatano E; Fujii H; Uyama N; Shimahara Y
    Ann Surg; 2006 Aug; 244(2):265-73. PubMed ID: 16858190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of combined hepatocellular and cholangiocarcinoma with hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
    Lee WS; Lee KW; Heo JS; Kim SJ; Choi SH; Kim YI; Joh JW
    Surg Today; 2006; 36(10):892-7. PubMed ID: 16998683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.
    Yin X; Zhang BH; Qiu SJ; Ren ZG; Zhou J; Chen XH; Zhou Y; Fan J
    Ann Surg Oncol; 2012 Sep; 19(9):2869-76. PubMed ID: 22451237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma in patients undergoing liver transplantation: a Spanish matched cohort multicenter study.
    Sapisochin G; de Lope CR; Gastaca M; de Urbina JO; López-Andujar R; Palacios F; Ramos E; Fabregat J; Castroagudín JF; Varo E; Pons JA; Parrilla P; González-Diéguez ML; Rodriguez M; Otero A; Vazquez MA; Zozaya G; Herrero JI; Antolin GS; Perez B; Ciria R; Rufian S; Fundora Y; Ferron JA; Guiberteau A; Blanco G; Varona MA; Barrera MA; Suarez MA; Santoyo J; Bruix J; Charco R
    Ann Surg; 2014 May; 259(5):944-52. PubMed ID: 24441817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcatheter arterial chemoembolization combined with radiofrequency ablation delays tumor progression and prolongs overall survival in patients with intermediate (BCLC B) hepatocellular carcinoma.
    Yin X; Zhang L; Wang YH; Zhang BH; Gan YH; Ge NL; Chen Y; Li LX; Ren ZG
    BMC Cancer; 2014 Nov; 14():849. PubMed ID: 25409554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixed hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma in patients undergoing transplantation for hepatocellular carcinoma.
    Sapisochin G; Fidelman N; Roberts JP; Yao FY
    Liver Transpl; 2011 Aug; 17(8):934-42. PubMed ID: 21438129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy].
    Yang W; Chen MH; Yan K; Gao W; Yin SS; Wang YB; Zhang XP; Xing BC; Huang XF
    Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):980-4. PubMed ID: 16194353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.